INNOVADERM CRO IS NOW INDERO.
READ THE ANNOUNCEMENT
Talk to us

Clinical research unit design – Platinum Winner – Grand Prix du Design

Indero

Indero

Team of Experts

Author picture

Platinum Winner – Grand Prix du Design – Health & Research Center

We are very proud to announce that L. McComber team has received an award for the stunning design of our state-of-the-art dermatology clinical research unit (CRU).

  • The CRU was specially designed allowing an ideal patient flow and optimal research activities in a very bright area.
  • The space was created to connect, collaborate and exchange in a large common area, and includes a beautiful terrace overlooking Mount Royal.
  • The focus is on clinical research, but also on the well-being of our patients and employees.

Interested in joining the team and working in this dazzling environment?

Several positions are available! Visit our career page and take a look at our clinic (photos by Raphaël Thibodeau):

clinical research unit

 

clinical research unit

 

clinical research unit

 

clinical research unit

 

clinical research unit

 

clinical research unit

SHARE THIS POST

Subscribe to our newsletter.

Do not miss out on valuable insights and research updates. Join our scientific community today!

This field is for validation purposes and should be left unchanged.
Talk to us

Jeff Smith

Chef de la direction
Linkedin

Jeff Smith, Chef de la direction d’Indero Recherches, apporte près de 30 ans d’expérience dans l’industrie pharmaceutique et CRO, s’étant distingué par son leadership exceptionnel, sa vision stratégique et son innovation. L’expertise de Jeff couvre des opérations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matière de création de valeur, de gestion des partenaires et d’opérations CRO ont toujours contribué au succès dans ses fonctions précédentes. Sous la direction de Jeff, Indero continue d’étendre ses capacités, faisant progresser les connaissances médicales et les nouvelles thérapies en dermatologie et en rhumatologie.

Revolutionize Your Topical Trials

Efficacy insights in days, not months.

 Indero’s Early Phase 1 model enables sponsors to initiate topical studies that detect early pharmacodynamic signals much sooner than traditional phase 1, using microdosing and transcriptomic analysis. This approach reduces preclinical requirements, shortens study duration from 8–12 weeks to ≤3 days, and lowers costs, helping teams make informed go/no-go decisions faster.
LEARN MORE >